, Obesity and colorectal cancer. Gut, vol.62, pp.933-947, 2013.
Prevalence of adenomas and colorectal cancer in average risk individuals: a systematic review and meta-analysis, Clin. Gastroenterol. Hepatol, vol.7, pp.1272-1278, 2009. ,
Étude épidémiologique, anatomopathologique et évaluation des facteurs pronostiques de l'adénocarcinome colorectal mucineux vs non mucineux, vol.88, pp.12-17, 2010. ,
Molecular basis for sunitinib efficacy and future clinical development, Nat. Rev. Drug Discov, vol.6, pp.734-745, 2007. ,
International quality assurance project in colorectal cancer-unifying diagnostic and histopathological evaluation, Langenbecks Arch. Surg, vol.399, pp.473-479, 2014. ,
, Tumor markers in colorectal cancer Cir, Cir, vol.81, pp.169-175, 2013.
, Microbiote et cancer colorectal: des bactéries génotoxiques dans le tractus intestinal, vol.195, pp.1295-1305, 2011.
Body mass index at different adult ages, weight change, and colorectal cancer risk in the National Institutes of Health-AARP Cohort, Am. J. Epidemiol, vol.176, pp.1130-1140, 2012. ,
Body mass index and screening for colorectal cancer: gender and attitudinal factors, CancerEpidemiol, vol.36, pp.400-408, 2012. ,
Significant association between interleukin-17A polymorphism and colorectal cancer, Tumour Biol, vol.35, pp.6627-6632, 2014. ,
Significant association between IL23R and IL17F polymorphisms and clinical features of colorectal cancer, Immunol. Lett, vol.158, pp.189-194, 2014. ,
Interleukin-17F T7488 allele is associated with a decreased risk of colorectal cancer and tumor progression, Gene, vol.561, pp.88-94, 2015. ,
, IL-17 and Th17 Cells, vol.27, pp.485-517, 2009.
Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells, Genes Cells, vol.18, pp.247-265, 2013. ,
Association between polymorphisms in interleukin-17A and interleukin-17F genes and risks of gastric cancer, Int. J. Cancer, vol.127, pp.86-92, 2010. ,
Association between IL-17A and IL-17F gene polymorphisms and risk of gastric cancer in a Chinese population, Genet. Mol. Res, vol.15, 2015. ,
Interleukin-17 and type 17 helper T cells, N. Engl. J. Med, vol.361, pp.888-898, 2009. ,
Involvement of IL-17 in Fas ligand-induced inflammation, Int. Immunol, vol.16, pp.1099-1108, 2004. ,
Interleukin-17: a promoter in colorectal cancer progression, Clin. Dev. Immunol, vol.2013, p.436307, 2013. ,
Interleukin-17 gene polymorphisms are associated with bladder cancer in a Chinese Han population, Mol. Carcinog, vol.52, pp.871-878, 2012. ,
Analysis of the association of interleukin-17 gene polymorphisms with gastric cancer risk and interaction with Helicobacter pylori infection in a Chinese population, Tumor Biol, vol.35, pp.1575-1580, 2014. ,
IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma, Biochem. Biophys. Res. Commun, vol.407, pp.348-354, 2011. ,
Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, Th2, Treg, Th17) in patients with colorectal cancer, Cancer Res, vol.71, pp.1263-1271, 2011. ,
Association analysis of IL-17A and IL-17F polymorphisms in Chinese Han women with breast cancer, PLoS ONE, vol.7, p.34400, 2012. ,
Association between polymorphisms in the interleukin 10 promoter region and susceptibility to inflammatory bowel disease, Mol. Bio. Rep, vol.41, pp.1299-1310, 2014. ,
Interleukin-10-1082A/G polymorphism and inflammatory bowel disease susceptibility: a meta-analysis based on 17,585 subjects, Cytokine, vol.61, pp.146-153, 2013. ,
, Cytokine, vol.110, pp.18-23, 2018.
Clinical study on gastric cancer susceptibility genes IL-10 -1082 and TNF ?, Genet. Mol. Res, vol.13, pp.10909-10912, 2014. ,
Effect of interleukin-17A and interleukin-17F gene polymorphisms on the risk of gastric cancer in a Chinese population, Gene, vol.10, pp.328-332, 2014. ,
Association between IL17 polymorphisms and risk of cervical cancer in Chinese women, Clin. Dev. Immunol, vol.2012, p.6, 2012. ,
Polymorphism in the interleukin-17A promoter contributes to gastric cancer, World. J. Gastroenterol, vol.19, pp.5693-5699, 2013. ,
Tc17 cells in patients with uterine cervical cancer, PLoS One, vol.9, p.86812, 2014. ,
The prognostic value of interleukin-17 in lung cancer: a systematic review with meta-analysis based on Chinese patients, PLoS One, vol.12, p.185168, 2017. ,
Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients, J. Hepatol, vol.50, pp.980-989, 2009. ,
L'augmentation des cellules productrices d'IL-17 est corrélée avec une survie et une lymphangiogenèse médiocres chez les patients atteints de CPNPC, Cancer du Poumon, vol.69, pp.348-354, 2010. ,
A high ROR?T/CD3 ratio is a strong prognostic factor for postoperative survival in advanced colorectal cancer: analysis of helper T cell lymphocytes (Th1, Th2, Th17 and regulatory T cells), Ann. Surg. Oncol, vol.23, pp.919-927, 2016. ,
Genetic polymorphism of interleukin-17A and -17F genes in gastric carcinogenesis, Hum. Immunol, vol.70, pp.547-551, 2009. ,
Role of IL-17A rs2275913 and IL-17F rs763780 polymorphisms in risk of cancer development: an updated meta-analysis, Sci. Rep, vol.6, p.20439, 2016. ,
, Cytokine, vol.110, pp.18-23, 2018.